Fig. 1: Schematic illustration showing the production of conditioned medium (CM) for ischemic disease therapy.

Left, Center: Preparation of CM enriched with ischemic disease targeting-angiogenic paracrine factors obtained from human adipose-derived stem cells (hADSCs). Right: Positive effects relevant to the treatment of ischemic disease are listed.